| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nature genetics 45 (12), 1452-1458, 2013 | 2762 | 2013 |
| Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization JM Orgogozo, S Gilman, JF Dartigues, B Laurent, M Puel, LC Kirby, ... Neurology 61 (1), 46-54, 2003 | 1593 | 2003 |
| Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial S Gilman, M Koller, RS Black, L Jenkins, SG Griffith, NC Fox, L Eisner, ... Neurology 64 (9), 1553-1562, 2005 | 1319 | 2005 |
| Genome-wide analysis of genetic loci associated with Alzheimer disease S Seshadri, AL Fitzpatrick, MA Ikram, AL DeStefano, V Gudnason, ... Jama 303 (18), 1832-1840, 2010 | 1187 | 2010 |
| Analysis of shared heritability in common disorders of the brain V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ... Science 360 (6395), 2018 | 611 | 2018 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 542 | 2019 |
| Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease NC Fox, RS Black, S Gilman, MN Rossor, SG Griffith, L Jenkins, M Koller Neurology 64 (9), 1563-1572, 2005 | 518 | 2005 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 429 | 2017 |
| Trial of solanezumab for mild dementia due to Alzheimer’s disease LS Honig, B Vellas, M Woodward, M Boada, R Bullock, M Borrie, K Hager, ... New England Journal of Medicine 378 (4), 321-330, 2018 | 425 | 2018 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 299 | 2001 |
| A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer’s disease L Tárraga, M Boada, G Modinos, A Espinosa, S Diego, A Morera, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (10), 1116-1121, 2006 | 283 | 2006 |
| A phase II trial of tideglusib in Alzheimer's disease S Lovestone, M Boada, B Dubois, M Hüll, JO Rinne, HJ Huppertz, ... Journal of Alzheimer's Disease 45 (1), 75-88, 2015 | 246 | 2015 |
| Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ... Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015 | 243 | 2015 |
| Frontotemporal dementia and its subtypes: a genome-wide association study R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ... The Lancet Neurology 13 (7), 686-699, 2014 | 220 | 2014 |
| Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis SC Neu, J Pa, W Kukull, D Beekly, A Kuzma, P Gangadharan, LS Wang, ... JAMA neurology 74 (10), 1178-1189, 2017 | 211 | 2017 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 199 | 2014 |
| Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ... Neurobiology of aging 31 (5), 725-731, 2010 | 189 | 2010 |
| Randomized trial of verubecestat for prodromal Alzheimer’s disease MF Egan, J Kost, T Voss, Y Mukai, PS Aisen, JL Cummings, PN Tariot, ... New England Journal of Medicine 380 (15), 1408-1420, 2019 | 186 | 2019 |
| A novel Alzheimer disease locus located near the gene encoding tau protein G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ... Molecular psychiatry 21 (1), 108-117, 2016 | 176 | 2016 |
| A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved A Espinosa, M Alegret, S Valero, G Vinyes-Junqué, I Hernández, ... Journal of Alzheimer's Disease 34 (3), 769-780, 2013 | 150 | 2013 |
